[ad_1] © Reuters. FILE PHOTO: The logo of Societe Generale is seen on the headquarters at the financial and business district of La Defense near Paris, France, February 4, 2020. REUTERS/Benoit Tessier PARIS (Reuters) – Societe Generale (OTC:), France’s third biggest bank, posted a higher-than-expected profit in the fourth quarter, driven by a strong performance … Read more
[ad_1] © Reuters Gilead Sciences shares gain after topping expectations despite lower remdesivir sales By Sam Boughedda Gilead Sciences (NASDAQ:) shares rallied in early Friday trading in reaction to the company’s latest earnings report, which saw it beat top and bottom-line consensus expectations. The biopharmaceutical company posted fourth-quarter of $1.67 per share, $0.17 above the … Read more
[ad_1] © Reuters. FILE PHOTO: Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly By Leroy Leo (Reuters) -Cigna Corp beat Wall Street estimates for quarterly profit on Friday, aided by a sharp fall in medical costs due to lower COVID-19-related hospitalizations. Health insurers … Read more
[ad_1] Euro area PPI rises to 1.1% in December, beating expectations [ad_2] Source link
[ad_1] © Reuters. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam/File Photo By Michael Erman and Sriparna Roy (Reuters) -Gilead Sciences Inc on Thursday reported a higher-than-expected fourth-quarter profit driven by strong demand for its HIV and cancer drugs, while COVID-19 antiviral Veklury had … Read more
